GRI Bio Statistics Share Statistics GRI Bio has 2.5M
shares outstanding. The number of shares has increased by 346.69%
in one year.
Shares Outstanding 2.5M Shares Change (YoY) 346.69% Shares Change (QoQ) 346.79% Owned by Institutions (%) n/a Shares Floating 2.5M Failed to Deliver (FTD) Shares 68 FTD / Avg. Volume 0.03%
Short Selling Information The latest short interest is 128.88K, so 5.16% of the outstanding
shares have been sold short.
Short Interest 128.88K Short % of Shares Out 5.16% Short % of Float 5.16% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -0.31 and the forward
PE ratio is -0.58.
GRI Bio's PEG ratio is
0.
PE Ratio -0.31 Forward PE -0.58 PS Ratio 0 Forward PS n/a PB Ratio 0.64 P/FCF Ratio -0.3 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for GRI Bio.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 3.43,
with a Debt / Equity ratio of 0.03.
Current Ratio 3.43 Quick Ratio 3.43 Debt / Equity 0.03 Debt / EBITDA -0.01 Debt / FCF -0.01 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-2.74M Employee Count 3 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -86.56% in the
last 52 weeks. The beta is -1.83, so GRI Bio's
price volatility has been lower than the market average.
Beta -1.83 52-Week Price Change -86.56% 50-Day Moving Average 1.53 200-Day Moving Average 6.83 Relative Strength Index (RSI) 37.26 Average Volume (20 Days) 250,282
Income Statement
Revenue n/a Gross Profit n/a Operating Income -8.23M Net Income -8.21M EBITDA -8.23M EBIT -8.23M Earnings Per Share (EPS) -55.21
Full Income Statement Balance Sheet The company has 5.03M in cash and 119K in
debt, giving a net cash position of 4.91M.
Cash & Cash Equivalents 5.03M Total Debt 119K Net Cash 4.91M Retained Earnings -39.74M Total Assets 4.04M Working Capital 1.15M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -8.61M
and capital expenditures 0, giving a free cash flow of -8.61M.
Operating Cash Flow -8.61M Capital Expenditures n/a Free Cash Flow -8.61M FCF Per Share -46.98
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields GRI does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for GRI is $22,
which is 1796.6% higher than the current price. The consensus rating is "Buy".
Price Target $22 Price Target Difference 1796.6% Analyst Consensus Buy Analyst Count 2
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Feb 24, 2025. It was a
backward
split with a ratio of 1:17.
Last Split Date Feb 24, 2025 Split Type backward Split Ratio 1:17
Scores Altman Z-Score -21.48 Piotroski F-Score 1
